01 1Bortezomib 3.5mg/vial
02 1Loncastuximab tesirine
03 1Patritumab deruxtecan
04 2Pemetrexed disodium heptahydrate
05 1sacituzumab govitecan
01 6BSP Pharmaceuticals
01 6Italy
NDC Package Code : 43624-024
Start Marketing Date : 2003-05-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (3.5mg/3.5mg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 43624-004
Start Marketing Date : 2021-05-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (10mg/10mg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 43624-021
Start Marketing Date : 2024-01-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/5mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 43624-006
Start Marketing Date : 2004-02-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER, FOR SOLUTION (500mg/20mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 43624-005
Start Marketing Date : 2008-01-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER, FOR SOLUTION (100mg/4.2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 43624-008
Start Marketing Date : 2020-04-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (180mg/180mg)
Marketing Category : DRUG FOR FURTHER PROCESSING
LOOKING FOR A SUPPLIER?
